Nanobiotix SA
NBTX
$2.81
Closing
▼-4.10%
1D
▼-61.40%
YTD
NBTX
BBG00Y9D2TR2
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$272.98M
Analysts' Rating
STRONG BUY
Price Target (Mean)
11.33
Total Analysts
2
P/E
Operating Margin
0.00%
Beta
0.44
Revenue Growth
0.00%
52 week high
$8.43
52 week low
$2.76
Div. Yield
%
EPS Growth
0.00
Company Profile
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company’s NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
